Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics

Published:2020-02 Issue:1 Volume:42 Page:83-92
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Rao Gauri G.,Konicki Robyn,Cattaneo Dario,Alffenaar Jan-Willem,Marriott Deborah J. E.,Neely Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference84 articles.

1. Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against mycobacterium tuberculosis;Ashtekar;Diagn Microbiol Infect Dis.,1991

2. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones;Jones;Antimicrob Agents Chemother.,1996

3. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis;Kaatz;Antimicrob Agents Chemother.,1996

4. In vitro activity of linezolid against staphylococci;Cuny;Clin Microbiol Infect.,2000

5. In vitro activity of linezolid against key Gram-positive organisms isolated in the United States: results of the LEADER 2004 surveillance program;Draghi;Antimicrob Agents Chemother.,2005

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis;International Journal of Antimicrobial Agents;2024-10

3. Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients;European Journal of Clinical Pharmacology;2024-08-25

4. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review;Antibiotics;2024-08-24

5. Pharmacokinetics and Safety of Linezolid Tablets of 2 Different Manufacturers in Healthy Chinese Subjects in Fasting and Fed States;Clinical Pharmacology in Drug Development;2024-08-19